SRC-2 drives castration-resistant prostate cancer

SRC-2 drives castration-resistant prostate cancer

Finding a blocker for the nuclear receptor coactivator known as NCoA2 or SRC-2 might solve the problem of treating advanced prostate cancer that becomes resistant to the most common treatmentdrugs that deprive the body of androgens, or male …

(Visited 1 times, 1 visits today)
1
Like
Save

Comments

Write a comment

*